9. Pharmacologic Approaches to Glycemic Treatment: Standards of Care in Diabetes—2023

The American Diabetes Association (ADA) "Standards of Care in Diabetes" includes the ADA's current clinical practice recommendations and is intended to provide the components of diabetes care, general treatment goals and guidelines, and tools to evaluate quality of care. For a detailed description of ADA standards, statements, and reports, as well as the evidence-grading system for ADA's clinical practice recommendations and a full list of Professional Practice Committee members, please refer to...

⚡ This is an original paraphrased summary — not copied from the abstract. Full paper available at the source link below.

• 1 Members of the ADA Professional Practice Committee, a multidisciplinary expert committee, are responsible for updating the Standards of Care annually, or more frequently as warranted.
• 2 For a detailed description of ADA standards, statements, and reports, as well as the evidence-grading system for ADA's clinical practice recommendations and a full list of Professional Practice Committee members, please refer to Introduction and Methodology.
• 3 Readers who wish to comment on the Standards of Care are invited to do so at professional.diabetes.org/SOC.

These innovations can translate to real-world improvements in technology, infrastructure, and everyday tools.

This summary is based on publicly available metadata and abstract. For the full research paper, visit the original source: